Ad Medicated Rash Ointment
NDC Package 65197-406-52
Package Information
Ad Medicated Rash ointment is apply as needed. This formulation utilizes a ointment delivery system. Marketed by Wellspring Pharmaceutical Corporation, this product is identified by NDC 65197-406 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 2710836 - colloidal oatmeal 2 % / mineral oil 30 % Topical Ointment
- RxCUI: 2710836 - colloidal oatmeal 0.02 MG/MG / mineral oil 0.3 MG/MG Topical Ointment
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Grain Proteins - [EXT]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 65197 - Wellspring Pharmaceutical Corporation
- 65197-406 - Ad Medicated Rash
- 65197-406-52 - 431 g in 1 JAR
- 65197-406 - Ad Medicated Rash
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65197-406). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65197-406-52 identifies a specific commercial package of 431 g in 1 jar of Ad Medicated Rash, a human over the counter drug labeled by Wellspring Pharmaceutical Corporation. This ointment is formulated for topical use and contains mineral oil; oatmeal as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wellspring Pharmaceutical Corporation on January 15, 2025. The current certification is valid through December 31, 2026.
How is this Wellspring Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65197040652. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.